Literature DB >> 10480669

California Verbal Learning Test practice effects in a schizophrenia sample.

K A Hawkins1, B E Wexler.   

Abstract

Practice effects on the California Verbal Learning Test (CVLT; >Delis et al., 1987), a measure of new learning and memory, were evaluated in a sample of patients with schizophrenia who were administered the CVLT at baseline, week 10, and week 14 in the context of a study of the effects of a non-pharmacological intervention on psychiatric status. Large effects attributable to prior exposure to the test were evident at weeks 10 and 14. These effects indicate that caution must be exercised in interpreting serial performances on this commonly used test, whether in research or clinical circumstances. Additionally, although the exact nature of the learning involved is unclear, the influence of prior exposure on later performance reveals considerable retention over time of new information in this sample of persons with schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10480669     DOI: 10.1016/s0920-9964(99)00015-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.

Authors:  Philip D Harvey; Michael F Green; Christopher Bowie; Antony Loebel
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

2.  Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.

Authors:  Taryn G Moss; Kristi A Sacco; Taryn M Allen; Andrea H Weinberger; Jennifer C Vessicchio; Tony P George
Journal:  Drug Alcohol Depend       Date:  2009-05-17       Impact factor: 4.492

3.  Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors:  S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

4.  Changes in cognition following mild stroke.

Authors:  Timothy J Wolf; Morgan C Rognstad
Journal:  Neuropsychol Rehabil       Date:  2012-12-03       Impact factor: 2.868

Review 5.  Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy.

Authors:  Kee-Hong Choi; Til Wykes; Matthew M Kurtz
Journal:  Br J Psychiatry       Date:  2013-09       Impact factor: 9.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.